CE-SDS IgG Standard Supply

The contract seeks the supply of CE-SDS IgG standards or equivalents suitable for size-based protein analysis, specifically engineered to integrate seamlessly with Maurice CE-SDS instrumentation workflows. Providers must ensure full compatibility with existing analytical platforms and deliver lot-specific quality documentation to support regulatory compliance and reproducibility in biopharmaceutical characterization. The standards must meet precise performance criteria to enable accurate molecular weight determination, purity assessment, and conformational analysis essential for product quality control. This subcontract, issued under the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, is classified under NAICS code 325414 for pharmaceutical and biological product manufacturing. The opportunity was posted on July 17, 2026, with responses required by July 24, 2026. While no set-aside designation or point of contact is specified, the performance location and agency address details are not provided, indicating flexibility in supply logistics. All proposals must demonstrate adherence to rigorous quality standards and the ability to consistently replicate batch-to-batch performance for use in critical biomedical applications.